Literature DB >> 2213776

Psychological screening in rheumatoid arthritis.

J C Parker1, S P Buckelew, K L Smarr, K L Buescher, N C Beck, R G Frank, S K Anderson, S E Walker.   

Abstract

Our objective was to examine the utility of the Symptom Checklist-90-R (SCL-90-R) as a psychological screening instrument for patients with rheumatoid arthritis (RA). Subjects were 81 male and 3 female patients with classic or definite RA who were categorized into 3 anatomic stage groups based on roentgenograms. Erythrocyte sedimentation rates, joint counts, and the SCL-90-R were obtained on all subjects. In addition, rheumatologists were surveyed, and items were analyzed to identify potential disease related items on the SCL-90-R. Both the survey and the item analyses supported the utility of the SCL-90-R as a psychological screening instrument in a population with RA.

Entities:  

Mesh:

Year:  1990        PMID: 2213776

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  11 in total

1.  Psychological distress, somatization, and defense mechanisms associated with quality of life in inflammatory bowel disease patients.

Authors:  Thomas N Hyphantis; Barbara Tomenson; Marina Bai; Epameinondas Tsianos; Venetsanos Mavreas; Francis Creed
Journal:  Dig Dis Sci       Date:  2009-03-03       Impact factor: 3.199

2.  Psychological distress and personality traits in early rheumatoid arthritis: A preliminary survey.

Authors:  T N Hyphantis; M Bai; V Siafaka; A N Georgiadis; P V Voulgari; V Mavreas; A A Drosos
Journal:  Rheumatol Int       Date:  2005-12-09       Impact factor: 2.631

3.  Illness perceptions and psychological distress associated with physical health-related quality of life in primary Sjögren's syndrome compared to systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Konstantinos Kotsis; Paraskevi V Voulgari; Niki Tsifetaki; Alexandros A Drosos; André F Carvalho; Thomas Hyphantis
Journal:  Rheumatol Int       Date:  2014-04-27       Impact factor: 2.631

4.  The relationship between depressive symptoms, illness perceptions and quality of life in ankylosing spondylitis in comparison to rheumatoid arthritis.

Authors:  Thomas Hyphantis; Konstantinos Kotsis; Niki Tsifetaki; Francis Creed; Alexandros A Drosos; André F Carvalho; Paraskevi V Voulgari
Journal:  Clin Rheumatol       Date:  2013-01-18       Impact factor: 2.980

5.  Ego mechanisms of defense are associated with patients' preference of treatment modality independent of psychological distress in end-stage renal disease.

Authors:  Thomas Hyphantis; Spiros Katsoudas; Sonia Voudiclari
Journal:  Patient Prefer Adherence       Date:  2010-03-24       Impact factor: 2.711

6.  Somatization is associated with physical health-related quality of life independent of anxiety and depression in cancer, glaucoma and rheumatological disorders.

Authors:  Thomas Hyphantis; Barbara Tomenson; Vassiliki Paika; Augoustina Almyroudi; Chrisavgi Pappa; Niki Tsifetaki; Paraskevi V Voulgari; Alexandros A Drosos; Nicholas Pavlidis; Francis Creed
Journal:  Qual Life Res       Date:  2009-08-22       Impact factor: 4.147

7.  Dentofacial disharmony: psychological status of patients seeking treatment consultation.

Authors:  C Phillips; M E Bennett; H L Broder
Journal:  Angle Orthod       Date:  1998-12       Impact factor: 2.079

8.  Illness behaviour in patients with arthritis.

Authors:  M J Ahern; A C McFarlane; A Leslie; J Eden; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1995-04       Impact factor: 19.103

9.  The bothersomeness of sciatica: patients' self-report of paresthesia, weakness and leg pain.

Authors:  Lars Grøvle; Anne Julsrud Haugen; Anne Keller; Bård Natvig; Jens Ivar Brox; Margreth Grotle
Journal:  Eur Spine J       Date:  2009-06-02       Impact factor: 3.134

10.  Determinants of sexual disability and dissatisfaction in female patients with rheumatoid arthritis.

Authors:  Ahmed M Abdel-Nasser; Essam I Ali
Journal:  Clin Rheumatol       Date:  2006-03-07       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.